Skip to main content
v2026.11,858 entries · CC-BY 4.0
LAC HealthMedical Supply Distributor100,000+ medical supplies. 48-hour critical dispatch.Ships from 8 regional U.S. hubs. Net-30 terms for verified institutional accounts.Shop lac.us CodeCASRAIlac.us

Beneficiary Inducement for Medical Suppliers: What the CMP Law Prohibits and the Exceptions

The beneficiary inducement civil monetary penalty law explained for medical suppliers: free items, the “should know” test, statutory exceptions and penalty exposure.

Written and maintained by CASRAI Editorial Board

Last updated

General information about a federal statute, not legal advice. Statute and regulation text checked on 2026-11-01.

Short answer

Beneficiary inducement is the civil monetary penalty (CMP) rule in section 1128A(a)(5) of the Social Security Act. It reaches a supplier that offers or transfers remuneration to a Medicare or State health care program beneficiary when the supplier knows or should know the remuneration is likely to influence that person to order or receive items or services from a particular supplier. Free items count as remuneration, and no proof of intent is required.

Definition and scope

The prohibition, codified at 42 U.S.C. 1320a-7a(a)(5), applies to a person who offers or transfers remuneration to an individual eligible for Medicare or a State health care program, where the remuneration is likely to influence the individual to order or receive from a particular provider, practitioner or supplier any item or service payable under those programs. The statute defines remuneration to include waiving coinsurance and deductible amounts and transferring items or services for free or for other than fair market value. The implementing regulation, 42 CFR 1003.110, repeats that definition.

This is a different concept from undue inducement of research participants, which is an ethics-review question; see inducements in research. It is also separate from the kickback rules that govern payments between providers and referral sources, covered in the Anti-Kickback Statute guide.

How the tests work in practice

The statute has elements that can be read as a sequence of questions. The Office of Inspector General (OIG) explained how it reads them in its August 2002 Special Advisory Bulletin on offering gifts and other inducements to beneficiaries.

Is it remuneration?

OIG’s bulletin says remuneration has been interpreted broadly to include anything of value. Under the statute, a free item, or one transferred below fair market value, qualifies.

Is it likely to influence the choice of supplier?

OIG says an offer of valuable goods or services as part of marketing or promotional activity meets the inducement element whether the activity is active or passive, which means word-of-mouth promotion is not outside the rule. OIG also considers free goods or services given to existing customers with an ongoing relationship likely to influence their future purchases.

Does the supplier “know or should know”?

OIG states that the “should know” standard is met by deliberate ignorance or reckless disregard, and that no proof of specific intent is required.

Does an exception apply?

The exceptions are listed in the Statutory exceptions section below. The rule applies regardless of the beneficiary’s medical condition, and OIG’s bulletin says that financial need by category, such as being on Medicaid, does not by itself justify valuable gifts.

Free items and DME giveaways

Free equipment and supplies are the standard example of a transfer for less than fair market value. OIG’s durable medical equipment page warns about telemarketers offering “free” items and notes that aggressive telemarketing can lead patients to receive more equipment than they need. OIG’s 2002 bulletin gives the rationale for the CMP: giveaways may lead to unnecessary services, or to cheaper or lower-quality services, and may favor large providers. For related fraud patterns, see DME fraud schemes.

Statutory exceptions

The statute’s definition of remuneration excludes the following, among others. Each has its own conditions in the text of 42 U.S.C. 1320a-7a(i)(6) and 42 CFR 1003.110.

Exception What the text conditions it on
Non-routine cost-sharing waiver Not advertised; made in good faith on individual financial need or after reasonable collection efforts fail
Free or discounted items or services given to individuals in financial need Not advertised, reasonably connected to medical care, and provided after a good-faith determination that the individual is in financial need
Retailer coupons, rebates or rewards Offered on equal terms to the general public regardless of insurance status; not tied to Medicare or Medicaid reimbursed items
Promotes access to care Improves the beneficiary’s ability to obtain covered items and services, with a low risk of harm, no skewing of clinical decisions, no overutilization, and no patient safety or quality concerns
Practices permitted under Anti-Kickback Statute safe harbors Must fit the safe harbor itself; see the GPO safe harbor guide for one example of how a safe harbor is structured

Civil monetary penalty exposure

The text of the statute provides a civil money penalty of not more than $20,000 for each item or service for violations of this kind, and says the Secretary may also determine in the same proceeding to exclude the person from participation in the Federal health care programs. Penalty amounts are adjusted for inflation each year, so the current figure has to be taken from the current regulation, not from the statute text. A related view of penalty layers is in Anti-Kickback Statute penalties for medical suppliers.

Questions to ask before giving a beneficiary anything free or discounted

This checklist is built from the statutory elements and the OIG bulletin. It is a set of questions to raise with compliance counsel, not a determination.

  • Is the item or service free, or below fair market value, or does it waive coinsurance or a deductible?
  • Is the recipient eligible for Medicare or a State health care program?
  • Is the offer advertised or promoted, including informally by word of mouth?
  • Is it tied to a particular supplier relationship, or offered only to existing customers?
  • Is financial need determined individually, rather than assumed because of a category such as Medicaid enrollment?
  • Is it offered on equal terms to the general public, and not linked to reimbursed items?
  • Which written exception, if any, is being relied on, and where is the documentation?

Common misunderstandings

  • “Small gifts are always fine.” The 2002 bulletin’s dollar figures are superseded. OIG has since issued a nominal-value policy statement; read its current text rather than relying on a figure quoted from older material.
  • “Medicaid recipients can always be helped.” OIG’s bulletin says categorical financial need is not a basis for valuable gifts.
  • “It is not marketing if we do not advertise.” Passive promotion and word of mouth count.
  • “Intent matters.” Reckless disregard satisfies “should know”; specific intent need not be proven.

FAQ

What is beneficiary inducement?

It is offering or giving remuneration to a Medicare or State health care program beneficiary that the giver knows or should know is likely to influence the beneficiary to choose a particular provider, practitioner or supplier for payable items or services (42 U.S.C. 1320a-7a(a)(5)).

Is a free DME item a beneficiary inducement?

A free item is remuneration under the statute. Whether it violates the CMP law depends on the likelihood of influencing supplier choice, the knowledge standard and whether an exception applies.

What is the civil monetary penalty for beneficiary inducement?

The statute provides up to $20,000 per item or service, adjusted annually for inflation, plus possible program exclusion. Check the current inflation-adjusted amount.

Does the rule cover Medicaid patients?

Yes. The prohibition covers individuals eligible under a State health care program as well as Medicare, and OIG’s bulletin says Medicaid status alone is not an exception.

Does it apply to drug manufacturers?

OIG’s bulletin says manufacturers are not providers, practitioners or suppliers under this provision unless they also own or operate entities such as pharmacies that bill the programs.

For a clinical-trial angle on billing exposure, see the False Claims Act guide for clinical trial billing.

Sources

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Beneficiary Inducement for Medical Suppliers: What the CMP Law Prohibits and the Exceptions

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →